The study is a multicenter, prospective cohort study designed to assess the natural history, clinical safety and efficacy of various treatment strategies in patients with cerebral arteriovenous malformations (AVMs) and intracranial aneurysms.
Patients diagnosed with cerebral arteriovenous malformation and intracranial aneurysm confirmed by CTA, MRA, and/or DSA;
Availability of complete clinical and imaging data;
Provision of written informed consent by the patient or their legally authorized representative to participate in the study and undergo follow-up;
Not concurrently participating in any other clinical trials that may interfere with the outcomes of this study.
Previous complete occlusion of the aneurysm and/or arteriovenous malformation prior to enrollment;
Coexistence of other cerebrovascular diseases such as moyamoya disease, cerebral cavernous malformation, cerebral venous sinus thrombosis, etc.;
Absence of DSA imaging data or poor image quality that precludes accurate evaluation of key anatomical and hemodynamic parameters of the AVM and intracranial aneurysm.
Duan Chuanzhi
Lead sponsor
Zhujiang Hospital
Sponsor institution
Beijing Tiantan Hospital
Collaborator
The First Affiliated Hospital of Zhengzhou University
Collaborator
The First Affiliated Hospital of Nanchang University
Collaborator
Second Affiliated Hospital of Nanchang University
Collaborator
Shenzhen Second People's Hospital
Collaborator
Guangdong 999 Brain Hospital
Collaborator